Calvin Q. Pan, MD

  • Specialty: Gastroenterology
  • Languages: English, Cantonese, Mandarin
  • Phone: 718-888-7728

About Me

Conditions and Treatments

hepatitis B, liver cancer, colonoscopy, liver cirrhosis, colon cancer, hepatitis C, liver transplantation, colon polyp, liver diseases, hepatorenal syndrome, colorectal cancer screening, hepatic encephalopathy, endoscopic surgery, hepatitis, cancer screening
Show More Conditions

Credentials

Positions
  • Clinical Professor, Department of Medicine
Education and Training
  • Residency, Long Island Jewish Medical Center, Medicine, 1996
  • MD from Guanzhou Medical College, 1985
Departments

Is this your profile?

Edit profile

Is this your profile?

Edit profile

Locations and Appointments

39 Insurance Plans Accepted
  • AETNA INDEMNITY
  • AETNA MEDICARE
  • AETNA POS
  • AETNA PPO/EPO
  • AFFINITY
  • Aetna HMO
  • CIGNA EPO/POS
  • Cigna PPO
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield Healthy NY
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Fidelis Medicaid
  • GHI
  • HIP ACCESS I
  • HIP ACCESS II
  • HIP Child Health
  • HIP EPO/PPO
  • HIP Family Health
  • HIP HMO
  • HIP MEDICAID
  • HIP MEDICARE
  • HORIZON NJ
  • LOCAL 1199 PPO
  • MAGNACARE PPO
  • Medicare
  • NY MEDICAID
  • Oxford Freedom
  • Oxford Liberty
  • Oxford Medicare
  • UnitedHealthcare Community & State Plan
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.

132-21 41st Avenue
Flushing, NY 11355

Research My Research

Interests

viral hepatitis

Research Summary

Dr. Pan's research interest is focus on the field of natural history of viral hepatitis, antiviral therapy and the prevention of vertical transmission of hepatitis virus.

He is currently a principle investigator for following clinical trials and most protocols enroll patients at the location of 132-21 Forty First Ave, Flushing,NY 11355. ---[1] Protocol # VX11-950-114 Project Title: A Phase 3b Study of 2 Treatment Durations of Telaprevir, PEG-INF (Pegasys), and Ribavirin (Copegus) in Treatment-Naive and Prior Relapser Subjects With Genotype 1 Chronic Hepatitis C and IL28B CC Genotype ---[2] Protocol # EMUMERATE Project Title: Entecavir Utilization, Management, and Efficacy in the United States: A Multi-center Study (ENUMERATE Study) ---[3] Protocol # ML27900 Project Title: An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1 (Peg Base USA) ---[4] Protocol # IN-US-174-0149 Project Title: A Phase 4, Randomized, Open-label, Active-Controlled, Superiority Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination with Peginterferon a-2a (Pegasys) versus Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon a-2a Monotherapy for 48 Weeks in Non-Cirrhotic Subjects with HBeAg-Positive or HBeAg-Negative ---[5] Protocol # IN-US-174-0174 Project Title: Tenofovir Disoproxil Fumarate in Late Pregnancy to Prevent Mother to Child Transmission of Hepatitis B Virus: A Multi-Center, Prospective, Randomized, Open-Label Study. ---[6] Protocol # ISR AI463-254 Project Title: An Observational Study on Proximal Tubular Dysfunction in Asian-American Patients Receiving Tenofovir Disoproxil Fumarate (TDF) or Entecavir (ETV) for HBV Treatment, ---[7] Protocol # HBV TRIAL AI452-005 Project Title: Dose-Ranging Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Pegylated Interferon Lambda (BMS-914143) Monotherapy in Interferon-Naive Patients with Chronic Hepatitis B Virus Infection who are HBeAg-positive ---[8] Protocol # IN-US-174-0156 Project Title: Long-term Observational Study on Anti-HBV Effect of Tenofovir Disoproxil Fumarate (TDF) and Resistance Surveillance in Asian-American Adult Patients Formerly Participating Gilead 123 Studies ---[9] Protocol # BMS AI463-198 Project Title: Clinical Presentation and Outcomes of Chronic Hepatitis B Virus (HBV) Infection in Asian Americans ---[10] Protocol # REALM TRIAL AI463080 Project Title: Randomized, Observational Study of Entecavir to Assess Long-term Outcomes Associated with Nucleoside/Nucleotide Monotherapy for Patients with Chronic HBV Infection

Research Interests Timeline

These focus areas and their associated publications are derived from PubMed and the MeSH term library.
represents one publication
Loading...

Publications

  • Clinical Features of Chronic Hepatitis B in Treatment-naive Asian Patients With Positive HBeAg and Coexisting Precore and/or Basal Core Promoter Mutations

    Pan, Calvin Q; Dai, Erhei; Bhamidimarri, Kalyan R; Zeng, Zheng; Yin, Paley Pan, Calvin Q; Dai, Erhei; Bhamidimarri, Kalyan R; Zeng, Zheng; Yin, Paley
    Journal of clinical gastroenterology. 2017 Mar. 51 (3): 261-267

  • Lamivudine therapy during the second vs the third trimester for preventing transmission of chronic hepatitis B

    Pan, C Q; Yi, W; Liu, M; Wan, G; Hu, Y-H; Zhou, M-F Pan, C Q; Yi, W; Liu, M; Wan, G; Hu, Y-H; Zhou, M-F
    Journal of viral hepatitis. 2017 Mar. 24 (3): 246-252

  • Efficacy and safety of endometrial ablation for treating abnormal uterine bleeding in pre- and postmenopausal women with liver cirrhosis

    Liu, Qing; Li, Xiu-Lan; Liu, Ji-Juan; Song, Xiao-Hong; Jiang, Xiao-Ying; Li, Wei; Zhang, Hua; Pan, Calvin Q Liu, Qing; Li, Xiu-Lan; Liu, Ji-Juan; Song, Xiao-Hong; Jiang, Xiao-Ying; Li, Wei; Zhang, Hua; Pan, Calvin Q
    Journal of obstetrics & gynaecology research. 2016 Dec. 42 (12): 1753-1760

Read All Publications (64)